Modeling- Everything You Wanted To Know, But Were Afraid To Ask

Published Sep 17, 2012
Princeton, NJ, USA - When designing a car or a home, builders first create a model: an accurate, yet smaller, representation of what the builder intends to build. Similarly, in health care, models are used to estimate future health care benefits as well as resource use. Key recommendations for best practices when modeling health care benefits and costs are presented in the paper, “Modeling Good Research Practices - Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1.” This overview paper is one in a series of seven papers that provide modeling best practices on the topics of: conceptualizing a model, estimating parameters and determining uncertainty, assuring a model is transparent and valid, as well as specific best practices on the following types of models: discrete event simulation models, dynamic transmission models and state-transition models. Lead author, Dr. Jaime Caro, MD says, “The ISPOR-SMDM Modeling Task Force papers reflect the extensive experience of 35 of the world's top health care research modelers and should serve our community well as a guide to what are the best practices for modeling to inform health care decisions.” This paper is jointly published in Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and Medical Decision Making, the official journal of the Society for Medical Decision Making (SMDM).

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health. For more information: www.ispor.org

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Launches New Content on Whole Health

Sep 23, 2025

ISPOR announced that it has launched new website content on whole health, a topic of increasing importance as health systems across the globe grapple with providing the best possible healthcare to patients within constrained budgets.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×